The class I myosin, Myosin 1b (Myo1b), is a widely-expressed, single-headed, actinassociated molecular motor. Transient kinetic and single-molecule studies indicate that it is kinetically slow and responds to tension. Localization and subcellular fractionation studies indicate that Myo1b associates with the plasma membrane and certain subcellular organelles such as endosomes and lysosomes. Whether Myo1b directly associates with membranes is unknown. We demonstrate here that full-length rat Myo1b binds specifically and with high affinity to phosphatidylinositol-4,5-bisphosphate (PIP 2 ) and phosphatidylinositol-3,4,5-triphosphate (PIP 3 ), two phophoinositides that play important roles in cell signaling. Binding is not Ca 2+ -dependent and does not involve the calmodulin-binding IQ region in the neck domain of Myo1b. Furthermore, the binding site is contained entirely within the C-terminal tail region, which contains a putative PH domain. Single mutations in the putative PH domain abolish binding of the tail domain of Myo1b to PIP 2 and PIP 3 in vitro. These same mutations alter the distribution of myc-tagged Myo1b at membrane protrusions in HeLa cells where PIP 2 localizes. In addition, we found that motor activity is required for Myo1b localization in filopodia. These results suggest that binding of Myo1b to phosphoinositides plays an important role in vivo by regulating localization to actin-enriched membrane projections.
Class I myosins are single-headed members of the myosin superfamily that bind actin filaments and produce mechanical force by hydrolyzing ATP. Class I myosins consist of an amino terminal head or motor domain containing the ATP-and actin-binding sites; a neck region containing repeats of a light chain-binding region known as an IQ domain; and a C-terminal tail domain. Class I myosins are widely expressed in protozoans and metazoans. In mammals, there are 8 class I myosins, Myo1a-h (1), which play roles in diverse cellular events such as membrane trafficking, formation of membrane protrusions, cell migration and transcription in the nucleus (2) .
The myosin I tail domain, a basic region referred to as the TH1 domain, is involved in membrane binding. Acanthamoeba myosin IC binds PS (phosphatidylserine) and PIP 2 and colocalizes with PIP 2 in dynamic regions of the plasma membrane including pseudopods, endocytic cups and the base of filopodia (3). Vertebrate Myo1a, abundant in the brush border of the small intestine, also binds PS and PIP 2 (4), suggesting that Myo1a tethers the core bundles of actin filaments in the microvilli directly to the membrane (5). The mammalian myosin I, Myo1c, which mediates GLUT 4 transport in adipocytes (6, 7) , and adaptation in the specialized hair cells of the inner ear (8, 9) , associates with phosphoinositides having phosphates at the 4-and 5-positions of the inositol ring (10) .
Vertebrate Myo1b is widely expressed in tissues including brain, heart, lung, kidney and liver (11) . Myo1b is kinetically slow and the interaction of actin-Myo1b with ATP is biphasic consisting of a fast phase followed by a slow phase (12, 13) . In single-molecule studies the interaction of Myo1b with actin can be separated into two mechanical phases, the first phase is thought to be associated with Pi release and the second phase is presumably associated with ADP release (14) . Moreover, like other class I myosins (15) (16) (17) (18) Myo1b exhibits an ADP-induced conformational change (Arthur, C., Lin, A., Coluccio, L. and Milligan, R. A., personal communication). The results from the kinetic, single-molecule and structural studies suggest that Myo1b undergoes a conformational change before ADP release and predict that this step is load dependent (12, 13) .
Single-molecule studies subsequently showed that the rate of Myo1b dissociation from actin is force-dependent (19) . The results implicate Myo1b as a force-sensing motor protein that can crosslink load-bearing actin filaments. Such a protein is better able to maintain and control cortical tension rather than to transport cargo (12) .
In fractionation studies of rat liver, Myo1b associates predominantly with the plasma membrane and endoplasmic reticulum (20) . In NRK cells, Myo1b is concentrated in actinenriched protrusions of the membrane such as ruffles and lamellipodia (21) . When expressed the tail domain localizes to the plasma membrane and associates with membrane fractions similar to fulllength Myo1b suggesting that the tail domain primarily determines the cellular localization (21) . Myo1b is also associated with endosomes and lysosomes whose distribution and morphology are affected by Myo1b overexpression (22, 23) .
Although Myo1b associates with membrane, whether it binds to membrane directly or indirectly, i.e. through a binding partner that binds to both Myo1b and membrane, is unknown. The specificity of Myo1b binding to membranes, and whether it resembles that of the other mammalian myosins I that have been studied to date, remains unclear. Thus, in this study, we investigated the interaction of Myo1b with lipids and its specificity. In addition, we examined the roles of Myo1b-lipid binding in determination of its cellular distribution.
EXPERIMENTAL PROCEDURES
Construction of Recombinant cDNAs-For expression in Sf9 insect cells, full-length Myo1b, Myo1b IQ domain and tail domain (Myo1b IQtail; D706-P1107) or the tail domain only (tail; V824-P1107) was amplified by PCR to contain a C-terminal FLAG tag using rat Myo1b cDNA as a template (the kind gift of Dr. Martin Bähler, University of Muenster). As a control the IQ and tail domain (Myo1c IQ-tail; A690-R1028) of mouse Myo1c was amplified by PCR to contain a C-terminal FLAG tag using EGFP-mouse Myo1c (a kind gift from Dr. Thomas Friedman, National Institutes of Deafness and Communication Diseases, NIH). The PCR products were then cloned into a pFastBac Dual vector (Invitrogen, Carlsbad, CA) containing a calmodulin expression cassette (24) . For expression in mammalian cells, Myo1b cDNAs in pFastBac Dual were amplified by PCR and ligated into pMyc (25) followed by verification of DNA by automatic sequencing. Point mutations were introduced by site-directed mutagenesis and verified by DNA sequencing. Espin/pCDNA3 construct (untagged) was kindly provided by Dr. James R. Bartles (Northwestern University, IL).
Protein Expression and Purification-The constructs were expressed in insect cells according to the manual provided for the Bac-to-Bac Baculovirus Expression System (Invitrogen). The infected insect cells were pelleted and homogenized in 50 mM Tris-HCl (pH 7.5), 300 mM KCl, 2 mM MgCl 2 , 1 mM EGTA, 2 mM ATP and protease inhibitors. After centrifugation at 200,000 x g for 30 min, anti-FLAG M2 agarose (Sigma Chem. Co., St. Louis, MO) was added to the supernatant and incubated for 1 h at 4 ˚C. The expressed protein was eluted with 100 µg/ml FLAG peptide in 30 mM HEPES (pH 7.5), 100 mM KCl, 2 mM MgCl 2 and 1 mM EGTA. Purified protein containing 10% sucrose and 1 mM DTT was stored at -80 ˚C.
Lipid-Bead-Protein Pull-Down Assay-PIP Bead Sample Pack (Echelon Biosciences Inc., Salt Lake City, UT) consisted of 50% slurries of 8 different phosphoinositide-coated beads and control beads containing no phosphoinositide. In each case 20 µl of the 50% slurry was washed by adding to 1 ml of binding buffer (30 mM HEPES, pH 7.5; 100 mM KCl, 2 mM MgCl 2 and 0.25% Igepal CA630) with 0.1 mM free calcium or 1 mM EGTA then centrifuging at 100 x g for 5 min at 4˚C. Purified Myo1b in 250 µl binding buffer (final concentration: 40 µg/ml) was incubated with the washed beads on a Labquake (Thermo Scientific, Asheville, NC) with gentle mixing for 90 min at 4˚C. The beads were collected at 100 x g for 5 min at 4˚C followed by washing three times with 500 µl binding buffer at 100 x g for 3 min each. The supernatant was removed and the bound protein was eluted with 20 µl 2X Laemmli sample buffer followed by analysis by SDS-PAGE and Coomassie-blue staining.
Liposome Pull-Down Assay-Myo1b IQ-tail (4 µM) or Myo1c IQ-tail (3.7 µM) was prespun at 353000 x g (Beckman TL100 centrifuge, TLA 100 rotor; Beckman Instruments, Palo Alto, CA) for 30 min at 25˚C in polycarbonate tubes (7 X 20 mm; Beckman Centrifuge Tubes #343775) to eliminate any aggregated protein. Then, Myo1b IQ-tail (final concentration: 25 nM) or Myo1c IQ-tail (final concentration: 50 nM) was incubated with various amounts (0-50 µM total lipid for Myo1b and 0-200 µM total lipid for Myo1c) of PolyPIPosomes (65% phosphatidylcholine, 30% phosphatidyl-ethanolamine, 5% PI, PIP 2 or PIP 3 ; Echelon Biosciences Inc.) in 200 µl of 30 mM HEPES (pH 7.5), 100 mM KCl, 2 mM MgCl 2 , 1 mM EGTA and 0.1 mg/ml BSA for 20 min at room temperature in the same polycarbonate centrifuge tubes only pretreated for 1 hr with 300 µl of 100 µM phosphatidylcholine to lessen the possibility of absorption of the liposomes to the tubes. The protein-liposome complexes were centrifuged at 353000 x g for 30 min at 25 ˚C. The pellets were resuspended in 12.5 µl 2X Laemmli sample buffer followed by analysis by SDS-PAGE and staining with Coomassie Brilliant Blue. The gels were scanned and analyzed using an Odyssey Infrared Imaging System (Licor, Lincoln, NE).
The data are expressed as percentage of bound Myo1b IQ-tail or Myo1c IQtail as a function of total lipid concentration and the data were fit to hyperbolae with Prism. K Lipid refers to the concentration of total lipid at which 50% of the protein is bound, whereas K PIP2 and K PIP3 are the concentrations of accessible PIP 2 and PIP 3 , respectively [(total lipid x 0.05)/2] at which 50% of the protein is bound.
Immunofluorescence Microscopy-HeLa or COS-7 cells were transfected using Fugene 6 (Roche Applied Science, Palo Alto, CA) then replated on poly-L-lysine-coated glass cover slips. The cells were fixed in 4% formaldehyde and 0.05% glutaraldehyde 24 h after transfection and were permeabilized and blocked in 0.5% saponin, 5% goat serum and 2.5% BSA in PBS for 1h, followed by overnight incubation with the appropriate primary antibodies in 0.1% saponin, 5% goat serum and 2.5% BSA in PBS. Primary antibodies used in this study were Myc-Tag polyclonal antibody (Cell Signaling Technology, Danvers, MA), and purified PI(4,5)P 2 mouse monoclonal antibody (Echelon Biosciences Inc. 2 and PIP 3 -To determine whether Myo1b interacts with phosphoinositides directly, we used a pull-down assay involving beads coated with various phosphoinositides and purified expressed fulllength Myo1b (Fig. 1B) . As shown in Fig. 2 To determine the phosphoinositide-binding domain of Myo1b, tail domain without the IQ motifs was used in pulldown assays (Fig. 1B, 2B ). The tail domain also showed specific binding to PIP 2 A putative PH domain is the binding site of phosphoinositides-Hokanson et al. (26) reported that Myo1c interacts with phosphoinositides through a PH domain and proposed that most mammalian class I myosins have a putative PH domain in the tail. Certain PH domains have a common secondary structure, β1-loop-β2, in which there are two conserved basic residues that are important for interacting with phosphoinositides (26, 27) . Myo1b tail domain has a putative PH domain containing a β1-loop-β2 structure and the corresponding two basic residues are conserved (K966 and R977) (Fig. 1A) . To determine whether these residues are involved in binding of Myo1b to specific phosphoinositides, we constructed two Myo1b tail mutants, K966A and R977A, (Fig. 1B) and examined the effect of these mutations on phospholipid binding using PIP-bead pull-down assays. Fig. 2B shows that a single alanine mutation at K966 or R977 completely abolished binding to PIP 2 and PIP 3 , suggesting that the K966 and R977 residues within the putative PH domain play an critical role in the interaction of Myo1b with PIP 2 and PIP 3 .
To test whether the IQ domain contributes to lipid binding, full-length Myo1b K966A (Fig. 1B) was used in pull-down assays with lipid-coated beads (Fig. 2C) . Since the tail mutation eliminates lipid binding via the putative PH domain in the tail, any observed lipid binding could potentially result from the IQ domain, which was initially thought to contribute to lipid binding in the case of Myo1c (8, 28 An accurate K PIP2 , the concentration of PIP 2 at which 50% of the protein is bound, could not be determined, but is estimated at 6 nM. The K PIP3 of Myo1b IQ-tail was determined to be 32 nM. More Myo1b (80%) associated with PolyPIPosomes containing 5% PIP 2 than with PolyPIPosomes containing 5% PIP 3 (50%). As the same Myo1b was used in each case this difference in behavior cannot be attributed to the use of different batches of protein. Furthermore, the protein was prespun to eliminate any aggregates and in the absence of PolyPIPosomes, little, if any, (2-3%) Myo1b pelleted indicating that the difference is also not due to the quality of the protein. One possibility is that the off rate is higher for PIP 3 vs. PIP 2 and that during centrifugation, more Myo1b dissociates from PIP 3 than from PIP 2 .
K PIP2 of Myo1c was also determined and is estimated to be 0.8 µM, which is close to previously reported values of 0.23 µM (29) and 0.53 µM (10). These results show that Myo1b has a higher affinity for PIP 2 than PIP 3 and a much higher affinity (>100-fold) for PIP 2 than does Myo1c.
Localization of Myo1b in filopodia requires phosphoinositide binding-To examine the effect of a mutation in the putative PH domain that abolishes the interaction of Myo1b with phosphoinositides on the cellular distribution of Myo1b, we transfected HeLa cells with myctagged full-length wild-type Myo1b or Myo1b K966A mutant (Fig. 1C) and stained with antimyc. Myc-tagged wild-type Myo1b was found at the cell periphery and in filopodia (Fig. 4A) as previously reported for endogenous and myctagged Myo1b (21) and GFP-tagged Myo1b (23, 30) in other cell types. Myo1b K966A mutant localized diffusely throughout the cytoplasm and was not concentrated at the periphery or in filopodia (Fig. 4D) . Transfected cells were also stained with PIP 2 antibodies (Fig. 4, B and E) in addition to anti-myc. PIP 2 antibodies strongly stained filopodia and the cell periphery where wild-type Myo1b (Fig. 4C ), but not Myo1b K966A mutant (Fig. 4F) , localized. These results suggest that phosphoinositide binding is required for localization of Myo1b in PIP 2 -enriched regions such as filopodia. Surprisingly, the R977A mutant localized diffusely in the cytoplasm like K966A, but also localized to filopodia like wild type (Fig.  4, G-I ).
Myo1b and PLCδ1-PH colocalized at the cell periphery and in filopodia-To monitor the Myo1b-PIP 2 interaction in cells, HeLa cells were transfected with PLCδ1-PH-GFP (31), a PIP 2 -specific binding protein, and myc-tagged fulllength Myo1b constructs (Fig. 5) . PLCδ1-PH-GFP was found at the cell periphery and in filopodia (Fig. 5, B and F) and wild-type Myo1b colocalized with PLCδ1-PH-GFP (Fig. 5, C and  D) . On the other hand, Myo1b K966A mutant did not colocalize with PLCδ1-PH-GFP (Fig. 5, E-H) . Myo1b R977A did not concentrate at the periphery and hence did not colocalize well with PLCδ1-PH (Fig. 5, I-L) .
Motor activity is required for localization in filopodia-We also examined whether motor activity is required for localization of Myo1b to filopodia, which contain an actin core. Amino acid residues R165 and G390 of Myo1b are located in the switch I and switch II regions, respectively. These sites are strictly conserved among myosins and replacement with alanine blocks ATP hydrolysis and isomerization, respectively. These myosins are held in the weakbinding state in ATP (32, 33) . We made myctagged Myo1b constructs in which R165 and G390 were mutated to alanine to render the Myo1b motors inactive.
These constructs were transfected into HeLa cells and stained with antimyc and anti-PIP 2 . Both mutants, R165A (Fig. 6,  A) and G390A (Fig. 6, D) , were concentrated in the cell periphery, but not in filopodia where PIP 2 is enriched (Fig. 6, B and E) . These mutants were also cotransfected into HeLa cells with PLCδ-PH-GFP (Fig. 7) . Both the R165A and G390A mutants colocalized with PLCδ1-PH-GFP at the cell periphery. These results indicate that although these mutants should be freely diffusing and can associate with the cell periphery, motor activity is required for Myo1b to enter and/or remain in filopodia.
Localization of Myo1b relative to PIP 2 in espin-induced filopodia of COS-7 cells-Because filopodia of HeLa cells are very thin making it difficult to see the localization of Myo1b and PIP 2 in detail, COS-7 cells were transfected with the actin-bundling protein, espin, which induces actin/membrane protrusions (34) . PIP 2 localized at the membrane of espin-induced filopodia ( Fig. 8,  C; Fig. S1, B and D) , whereas Myo1b localized within the core (Fig. 8, A and D, Fig. S1 , A, C, G and I). Actin filaments, stained with phalloidin, colocalized with Myo1b (Fig. 8, B and D; Fig. S1, 
E, F, H and I).

DISCUSSION
Ca
2+ -independent Myo1b-lipid binding is through the tail domain-In this study, we show direct binding of Myo1b through the putative PH domain in the tail domain to PIP 2 and PIP 3 , two phosphoinositides that play major roles in cell signaling cascades that lead to important cellular events such as reorganization of the actin cytoskeleton. The results can be compared to those with the related mammalian myosin I, Myo1c. Hirono et al. reported that Myo1c binds phosphoinositide through the IQ motif upon dissociation of calmodulin by calcium (9) . On the other hand, Hokanson et al. demonstrated that the Myo1c tail without the IQ domain is the major binding domain to lipid and that binding is not calcium/calmodulin dependent (29) .
In the presence of calcium, the motor activity of Myo1b is inhibited and this inhibition is reversed in the presence of exogenous calmodulin suggesting that calcium induces dissociation of one or more calmodulins from the neck region of Myo1b (35); however, binding of full-length Mo1b to phosphoinositides is not Ca 2+ dependent and the tail domain without the IQ motifs binds both PIP 2 and PIP 3 (Fig. 2A) . That the IQ domain plays no role in lipid binding in the case of Myo1b was further confirmed using the full-length Myo1b K966A tail mutant, which showed no binding to PIP 2 or PIP 3 in the presence or absence of Ca 2+ (Fig. 2C) .
Acanthamoeba myoC (3) and chicken Myo1a (4) bind PS and PIP 2 ; specificity to other phosphoinositides has not been investigated. Mouse Myo1c also binds to PIP 2 ; however, binding is not specific for this particular phosphoinositide because Myo1c also binds to other phosphoinositides having phosphates on position 4 and 5 of the inositol headgroup with a similar affinity (29) . Mutation of the conserved basic residues K872A and R903A in the β1-loop-β2 motif of the putative PH domain of mouse Myo1c decreased its affinity for phosphoinositides by more than 8 fold, while the equivalent mutation in Acanthamoeba myoC, R779A, resulted in only a 2-4 fold decrease in affinity for PS and PIP 2 .
Both of the homologous mutations in the β1-loop-β2 motif of Myo1b, K966A and R977A, completely abolished binding to PIP 2 and PIP 3 in vitro (Fig. 2B for K966A and R977A) ; moreover, the K966A mutant localized diffusely in the cytoplasm and lost the specific distribution at the cell periphery and filopodia found for wild type (Fig. 4, 5) . Although the R977A mutant also localized diffusely in the cytoplasm, it was found in filopodia (Fig. 4G, 5I) . The difference is localization between the two tail mutants, neither of which bind PIP 2 or PIP 3 in vitro, can be explained by small differences in affinity for lipids between the two mutants with the affinity of R977A for PIP 2 and/or PIP 3 exceeding that of K966A.
In the cell these slightly different affinities for phosphoinositides could lead to differential localization.
Specificity and affinity of Myo1b-phosphoinositide binding-Although Myo1b binds both PIP 2 and PIP 3 in vitro, its affinity for PIP 2 exceeds that of PIP 3 (Fig. 3) . In addition, the cellular concentration of PIP 3 is much less than PIP 2 (36) . Expression in HeLa cells of PLCδ1-PH-GFP, a specific PIP 2 -binding protein, demonstrates that PIP 2 is concentrated at the cell periphery and in filopodia in which Myo1b colocalizes with PIP 2 (Fig. 5) , while Btk-PH-GFP (37) , which binds specifically to PIP 3 , is found throughout the cytoplasm (Fig. S2) . Together, the evidence from in vitro and in vivo studies indicates that Myo1b is more likely to associate with PIP 2 than PIP 3 in HeLa cells. Upon stimulation, PIP 2 and PIP 3 levels dramatically increase in cells (36) . Sharma et al. reported that in stimulated neutrophils, PIP 2 and PIP 3 localize to the leading edge of cells (38) . Myo1b localization may also change upon stimulation involving an increase in PIP 2 and PIP 3 .
The affinity of Myo1b for PIP 2 is substantially higher than that determined for Myo1c with the same method (this report; Fig. 3 ) or similar methods (10, 29) . Myo1b's high affinity for PIP 2 might explain why Myo1b is more concentrated at the cell periphery than is Myo1c (21) .
Physiological role of Myo1b-lipid binding-PIP 2 plays an important role in actin reorganization in cellular protrusions. Many actinbinding proteins that regulate actin dynamics by capping, severing, branching and bundling actin interact with and are activated by PIP 2 (39) . These actin-binding proteins are thought to function in membrane-cytoskeleton interactions (40) . Reduction of cellular PIP 2 by expression of PLCδ1-PH, which sequesters PIP 2 , or by targeting 5'-PIP 2 -phosphatase to the plasma membrane results in a decrease in plasma membranecytoskeletal adhesion energy (41) . Activation of phospholipase-C by ionomycin and calcium that results in a decrease in the cellular PIP 2 level leads to translocation of Myo1c from the plasma membrane to the cytoplasm (29) . Myo1b may also be regulated by PIP 2 given its localization at the membrane in regions exhibiting dynamic rearrangements of the actin cytoskeleton.
In HeLa and COS-7 cells Myo1b localizes preferentially in filopodia, dynamic structures believed to sense the microenvironment and to determine the direction of cell movement. Filopodia are actin-filled membrane protrusions that function in diverse cellular processes such as cell migration, neurite outgrowth, and wound healing (42) . The length of actin filaments in the core bundle is a consequence of actin polymerization and depolymerization, mediated by actin-binding proteins, which sever and cap filaments or bundle actin filaments. During the dynamic process of filopodia formation the interaction of actin filaments with the membrane must be coordinated. The ability of Myo1b to sense tension between the membrane and the actin cytoskeleton (43) makes it an excellent candidate for regulating such actin-membrane interactions.
HeLa cells expressing motor-dead Myo1b or Myo1b unable to bind lipids have many filopodia similar to that of untransfected cells and cells expressing wild-type Myo1b.
Raposo and colleagues demonstrated that overexpression of GFP-labeled wild-type Myo1b or Myo1b mutant in the motor domain affects the distribution of transferrin receptors in the hepatoma cell line, BWTG3 (22) . Together, these results suggest that Myo1b mutants have a dominant negative effect on endocytosis, but not on filopodia.
Other class I myosins that bind phosphoinositides also localize to actin-enriched cell protrusions. Myo1a localizes to the lateral links found between the core bundle of actin filaments and the membrane in microvilli of the small intestine (5, 44, 45) . Microvilli shed small vesicles into the intestinal lumen and this activity is perturbed in Myo1a-deficient mice suggesting a role for Myo1a in vesicle production (46) . Myo1c is found in the brush border of the proximal tubules in kidney cells (47) , in the stereocilia of the hair cells in the inner ear (48) , and in membrane ruffles where it supports vesicle fusion with the plasma membrane (7, 49, 50) . In Myo1a knock-out mice, other myosins I redistribute to the microvilli and may compensate for the lack of Myo1a (5, 51) . Similarly, other myosins I may also compensate for Myo1b in cells expressing mutant Myo1b.
In addition to class I myosins, other myosins are involved in actin-membrane interactions. Myosin VI, a minus-ended-directed motor (52), binds PIP 2 and dimerizes upon binding (53) . In the renal brush border, myosin VI is required for parathyroid hormone-induced internalization of the sodium phosphate cotransporter and moves down along the actin bundle toward the base of microvilli (minus end of actin filament) together with the membrane-integrated transporter (54) .
We show here that Myo1b localizes within filopodia adjacent to both PIP 2 and actin filaments within filopodia (Fig. 8) and hypothesize that Myo1b associates with actin bundles and the plasma membrane and plays a role similar to the role of Myo1a in microvilli. The requirement of motor activity for Myo1b for proper localization to filopodia (Fig. 6, 7 ) supports this idea and suggests that whereas a motor-independent mechanism is responsible for Myo1b's location at the plasma membrane, Myo1b must actively move into filopodia. Myo1b's ability to sense mechanical force and to change its motor properties depending on load (13, 19) presumably allows Myo1b to regulate actin/membrane dynamics in addition to anchoring actin filaments to the plasma membrane.
While this paper was under revision, a report appeared in which it was predicted based on a computer program designed to recognize unstructured membrane-binding sites in protein sequences that the tail of Myo1b binds lipids through an unstructured basic and hydrophobic (BH) region, rather than through a highly defined tertiary structure such as a PH domain (55) . No such BH region was identified in the tail of Myo1c, consistent with the previous identification of a PH domain in its tail (10) . However, our studies provide experimental evidence clearly demonstrating that a PH domain exists in Myo1b and is responsible for lipid binding of Myo1b both in vitro and in vivo.
During this same time, two other reports showed that a PH-domain-like motif in the tail (and the motor domain) contribute to the localization of mammalian Myo1g to the plasma membrane (56, 57) .
Although not yet rigorously tested, the specificity of Myo1g for lipids appears distinct from that of Myo1c suggesting, as our studies with Myo1b show, that different class I myosins have different affinities for phosphoinositides.
